Publisher
Springer Science and Business Media LLC
Reference64 articles.
1. Acland K, Evans AV, Abraha H et al. (2002) Serum S100 concentrations are not useful in predicting micrometastatic disease in cutaneous malignant melanoma. Br J Dermatol 146: 832?835
2. Agrup P, Carstam R, Wittbjer A, Rorsman H, Rosengren E (1989) Tyrosinase activity in serum from patients with malignant melanoma. Acta Derm Venereol 69: 120?124
3. Balch CM, Buzaid AC, Soong SJ et al. (2001) Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 19: 3635?3648
4. Banfalvi T, Gilde K, Gergye M, Boldizsar M, Kremmer T, Otto S (2003) Use of serum 5-S-CD and S-100B protein levels to monitor the clinical course of malignant melanoma. Eur J Cancer 39: 164?169
5. Blesch A, Bosserhoff AK, Apfel R et al. (1994) Cloning of a novel malignant melanoma-derived growth-regulatory protein, MIA. Cancer Res 54: 5695?5701
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献